Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Roth

Showing results (51-60 of 357) with videos related to

Pageof 36
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1976
Role of blood flow in carbon monoxide- and hypoxic hypoxia-induced alterations in hexobarbital metabolism in ratsR A Roth, R J Rubin
Toxicology and Applied Pharmacology|November 1, 1988
Dieldrin activates rat neutrophils in vitroJ A Hewett, R A Roth
British Journal of Pharmacology|October 1, 1993
Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cellsC M Hoorn, R A Roth
Pharmacology & Therapeutics|January 1, 1985
Monoclonal antibodies to the insulin receptorR A Roth, D O Morgan
Pharmacological Reviews|December 1, 1993
Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharidesJ A Hewett, R A Roth
Toxicology and Applied Pharmacology|July 1, 1993
Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrroleA E Schultze, R A Roth
The Journal of Biological Chemistry|January 27, 1995
Characterization of the endogenous insulin receptor-related receptor in neuroblastomasK S Kovacina, R A Roth
British Journal of Pharmacology|June 1, 1984
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazoneK S Hilliker, R A Roth
Clinical Pharmacokinetics|September 1, 1979
Role of the lung in total body clearance of circulating drugsR A Roth, D A Wiersma
Toxicology and Applied Pharmacology|April 1, 1987
5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrroleP E Ganey, R A Roth
Pageof 36

Showing results (51-60 of 357) with videos related to

Sort By:
Pageof 36
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1976
Role of blood flow in carbon monoxide- and hypoxic hypoxia-induced alterations in hexobarbital metabolism in ratsR A Roth, R J Rubin
Toxicology and Applied Pharmacology|November 1, 1988
Dieldrin activates rat neutrophils in vitroJ A Hewett, R A Roth
British Journal of Pharmacology|October 1, 1993
Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cellsC M Hoorn, R A Roth
Pharmacology & Therapeutics|January 1, 1985
Monoclonal antibodies to the insulin receptorR A Roth, D O Morgan
Pharmacological Reviews|December 1, 1993
Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharidesJ A Hewett, R A Roth
Toxicology and Applied Pharmacology|July 1, 1993
Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrroleA E Schultze, R A Roth
The Journal of Biological Chemistry|January 27, 1995
Characterization of the endogenous insulin receptor-related receptor in neuroblastomasK S Kovacina, R A Roth
British Journal of Pharmacology|June 1, 1984
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazoneK S Hilliker, R A Roth
Clinical Pharmacokinetics|September 1, 1979
Role of the lung in total body clearance of circulating drugsR A Roth, D A Wiersma
Toxicology and Applied Pharmacology|April 1, 1987
5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrroleP E Ganey, R A Roth
Pageof 36